Ciclopirox ethanolamine
 OpenBabel02212023462D

 19 19  0  0  0  0  0  0  0  0999 V2000
    1.0312   -0.3572    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.2062   -0.3572    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2062    0.3572    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0312    0.3572    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.1284    2.2000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1284    1.3750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8429    0.9625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8429    0.1375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5574   -0.2750    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.1284   -0.2750    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.1284   -1.1000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.4139    0.1375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4139    0.9625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6995   -0.2750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6995   -1.1000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9850   -1.5125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2705   -1.1000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2705   -0.2750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9850    0.1375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
  3  4  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  2  0  0  0  0
  6 13  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  2  0  0  0  0
  8 10  1  0  0  0  0
 10 11  1  0  0  0  0
 10 12  1  0  0  0  0
 12 13  2  0  0  0  0
 12 14  1  0  0  0  0
 14 15  1  0  0  0  0
 14 19  1  0  0  0  0
 15 16  1  0  0  0  0
 16 17  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  1  0  0  0  0
M  END
>  <CdId>
647

>  <Mol Weight>
268.352

>  <Formula>
C14H24N2O3

>  <ID>
T1114

>  <Name>
Ciclopirox ethanolamine

>  <Synonyms>
Ciclopirox olamine

>  <CAS>
41621-49-2

>  <Approved status>
FDA

>  <Disease>
Immune system

>  <Indication>
Superficial Mycoses

>  <Pathways>
Membrane transporter/Ion channel; Others

>  <Target>
ATPase inhibitor; Others

>  <Receptor>
ATPase; iron

$$$$
